Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2026 -0.131M
June 30, 2026 -0.152M
March 31, 2026 -0.146M
December 31, 2025 -0.142M
September 30, 2025 -0.119M
June 30, 2025 -0.169M
March 31, 2025 -0.178M
December 31, 2024 -0.186M
September 30, 2024 -0.474M
June 30, 2024 -0.388M
March 31, 2024 -0.345M
December 31, 2023 -0.322M
September 30, 2023 -0.06M
June 30, 2023 -0.10M
March 31, 2023 -0.183M
December 31, 2022 -0.204M
September 30, 2022 -0.246M
Date Value
June 30, 2022 -0.293M
March 31, 2022 -0.296M
December 31, 2021 -0.344M
September 30, 2021 -0.345M
June 30, 2021 -0.342M
March 31, 2021 -0.335M
December 31, 2020 -0.332M
September 30, 2020 -0.323M
June 30, 2020 -0.298M
March 31, 2020 -0.252M
December 31, 2019 -0.188M
September 30, 2019 -0.121M
June 30, 2019 -0.07M
March 31, 2019 -0.036M
June 30, 2018 -0.017M
March 31, 2018 -0.008M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Korsana Biosciences, Inc. -0.033M
PepGen Inc. -1.155M
Q32 Bio, Inc. 53.39M
Bridgebio Oncology Therapeutics, Inc. -0.763M
Oncolytics Biotech, Inc. -0.048M